A clinical trial to study the effect of panchavalkal arka in treating patients with white discharge per vagina (vulvo vaginal candidiasis)

Clinical evaluation of the effect of panchavalkal arka in kaphaja yoni vyapat(vulvovaginal candidiasis)

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/09/046079

Enrollment

Registered

2022-09-30

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N768- Other specified inflammation of vagina and vulva

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Married women 2.Subjects fulfilling diagnostic criteria and having local signs and symptoms of kaphaja yoni vyapat as described in texts such as shweta and picchilasrava , yoni kandu and alpa vedana 3.wet vaginal smear postive for candida albicans or microscopically positive for pseudohyphea

Exclusion criteria

Exclusion criteria: 1.Pregnant and lactating women 2.subjects positive for HIV,VDRL,HBsAG 3.Systemic diseases like diabets mellitus 4.Subjects on hormonal medications like contraception or regulation of menstruation 5.Subjects who have had anti fungal coverage within 1 month or corticosteriods for less than past 6 months

Design outcomes

Primary

Measure	Time frame
Major symptoms like curdy white discharge, vulval and vaginal itching should be cured.Timepoint: Assessment will be done at baseline,follow up on 7th and 15 th day.Vaginal smear will be repeated on 15 th day for result.	—

Secondary

Measure	Time frame
Other symptoms like backache,pain during coitus should also be reduced.Timepoint: 15 days	—

Countries

India

Contacts

Public ContactDr Gayathri Bhat NV

Sri Dharmasthala Manjunatheswara College of Ayurveda and hospital, Hassan

gaya3hassan@gmail.com9844437917

Outcome results